What percentage of Moderna stock is owned by institutional investors?
Institutional investors and hedge funds own 75.33% of Moderna's stock.&ref=yanuki.com
Yanuki
ARTICLE DETAIL
Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions | Verizon Delivers Strong Q4 2025 Results, Exceeds Expectations | U.S. Bancorp Acquires BTIG for Up to $1 Billion | Robinhood Stock Surges After Q2 Earnings Report Amid Crypto Revenue Boost | Ford Motor Company: Institutional Investment and Analyst Updates (July 2025) | Volcon Announces $500M Private Placement to Initiate Bitcoin Treasury Strategy | Lucid Group Proposes 1:10 Reverse Stock Split: Will it Attract Investors? | Xcel Energy (XEL) Institutional Investor Activity | Alibaba's Profits Decline Due to Ant Group's Investments | Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions | Verizon Delivers Strong Q4 2025 Results, Exceeds Expectations | U.S. Bancorp Acquires BTIG for Up to $1 Billion | Robinhood Stock Surges After Q2 Earnings Report Amid Crypto Revenue Boost | Ford Motor Company: Institutional Investment and Analyst Updates (July 2025) | Volcon Announces $500M Private Placement to Initiate Bitcoin Treasury Strategy | Lucid Group Proposes 1:10 Reverse Stock Split: Will it Attract Investors? | Xcel Energy (XEL) Institutional Investor Activity | Alibaba's Profits Decline Due to Ant Group's Investments
Financial / Stock Market
Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions
Recent SEC filings reveal significant activity in Moderna (MRNA) stock by institutional investors. This article summarizes these transactions, providing insights into institutional sentiment towards the biotechnology company. Understanding...
Key Insights
- Several institutional investors have adjusted their positions in Moderna during the first and fourth quarters of 2025.
- ABC Arbitrage SA initiated a new position, purchasing 54,198 shares valued at approximately $1.5 million.&ref=yanuki.com
- LPL Financial LLC increased its stake by 83.8%, acquiring an additional 308,334 shares.&ref=yanuki.com
- Envestnet Asset Management Inc. reduced its holdings by 40.3%, selling 12,212 shares.&ref=yanuki.com
- Overall, institutional investors hold 75.33% of Moderna's stock.&ref=yanuki.com
- Analyst ratings are mixed, with a consensus rating of "Hold" and an average price target of $45.61.&ref=yanuki.com
In-Depth Analysis
Moderna, Inc. (NASDAQ:MRNA) has seen considerable activity from institutional investors recently. These transactions provide a glimpse into how major investment firms view the company's potential.
**Notable Transactions:**
- **ABC Arbitrage SA:** Took a new position in Moderna, purchasing 54,198 shares valued at around $1.5 million.&ref=yanuki.com
- **LPL Financial LLC:** Significantly increased its stake by 83.8%, acquiring 308,334 shares. Now owns 676,212 shares valued at $19.171 million.&ref=yanuki.com
- **Envestnet Asset Management Inc.:** Reduced its position by 40.3%, selling 12,212 shares. Remaining holdings are 18,102 shares valued at $513,000.&ref=yanuki.com
- **FMR LLC:** Increased its stake by 7.4% during Q4, now owning 18,664,634 shares valued at $776.075 million.&ref=yanuki.com
- **Invesco Ltd.:** Increased its stake by 24.3% during Q4, now holding 5,006,462 shares valued at $208.169 million.&ref=yanuki.com
**Analyst Ratings:**
Analysts have a mixed view of Moderna. The consensus rating is "Hold," with an average price target of $45.61. Recent reports include:
- **Citigroup:** Initiated coverage with a "Neutral" rating and a $40 price target.&ref=yanuki.com
- **Royal Bank of Canada:** Cut their price target from $32 to $28, maintaining a "Sector Perform" rating.&ref=yanuki.com
- **UBS Group:** Decreased their price objective from $78 to $70, keeping a "Buy" rating.&ref=yanuki.com
Moderna's stock opened at $27.64 on Tuesday and has a market cap of $10.69 billion. The stock's 50-day moving average is $29.22, and its 200-day moving average is $30.24. Institutional investors and hedge funds own 75.33% of the company's stock, indicating strong institutional interest.&ref=yanuki.com
FAQ
What is the average analyst rating for Moderna?
Moderna has an average rating of "Hold" among analysts.&ref=yanuki.com
What was Moderna's revenue for the last quarter?
Moderna reported revenue of $142.00 million for the quarter.&ref=yanuki.com
Takeaways
- Institutional investor activity provides insights into market sentiment regarding Moderna.
- A significant percentage of Moderna's stock is held by institutional investors, indicating strong interest from major players.
- Analyst ratings are mixed, suggesting a cautious approach to the stock.
Discussion
Do you think institutional investment activity is a reliable indicator of Moderna's future performance? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.